Develop new global growth opportunities for the Cavagna Group:• Lead portfolio development in high purity and specialty gases market.• Expand focus in hydrogen and cryogenic applications.• Technical liaison for global Tier I customers.• Initiate rollout for North American homecare devices product offerings.• Voting member and company representative at the Compressed Gas Association.

Supervised remotely global team for the development of new PSO (Products and Services Offerings) of compressed gas packages in food & beverage, aerospace, fuel cells, and environmental monitoring applications.• Directed strategy roadmap, ideation, competitive overview, and market trend analyses.• Initiated 3 to 4 new programs annually.• Controlled R&D development pipeline of $55MM growth offerings.• Promoted global replication of recently commercialized initiatives on track for $26MM 2021 revenue.• Introduced new hydrogen package for fuel cell generator, global telemetry applications for fixed and mobile assets, high capacity environment packages, and new whipped cream foaming solution.• Key member of strategic global growth forum for new packages and applications tasked with $300MM new growth focus. • Oversaw European and North American analytical and calibration laboratories.

Oversaw global healthcare network and led commercial launch of new high growth medical initiatives.• Presented strategic vision and technology initiatives to CEO, Office of the Chairman, and region presidents.• Directed assessment of market needs, competition, regulatory compliance, product development and business opportunities.• Pioneered international competition for external start-up medical gas innovation.• Managed generic drug application for inhaled Nitric Oxide in the USA, on track for $70MM revenue since launch.• Commercialized Praxair's first digital integrated cylinder valve with 50,000 units in 2 years.• Managed international external suppliers and vendors commercial relationships.• Tracked global quality reporting for medical equipment; aligned regulatory requirements prior to closing of the merger.

Led global network to drive growth in Praxair's specialty gases and healthcare markets.• Directed evaluation, development, and execution of new business opportunities in key growth markets.• Streamlined R&D direction and developed technology roadmap for new-products and services.• Drove $10+ MM annual global applications growth from new offerings.• Identified acquisition opportunity and spearheaded due diligence process for purchase of NOxBOX, Ltd, a mid-sized UK-based medical device manufacturing company.• Introduced new Nitric Oxide therapy in Canada, Germany, and India.• Trained full Asian team and prepared modules for use with other countries.• Devised and introduced new global branding strategy for Praxair specialty gases.

Rebuilt and supervised the healthcare R&D team following strategic corporate realignment.• Hired, developed, and managed the team of 7 associates.• Devised and implemented comprehensive 5-year strategic growth roadmap.• Supervised portfolio of over 20 active R&D projects with global customers and suppliers.• Launched new generations of portable gas packages for new gases (heliox, N2O/O2), cylinders (small and large volumes), and new electronics alarming functionalities. Ensured global alignment and compliance. Over 160,000 valves currently in service from new supplier.• Initiated first generic drug application program for Praxair. Oversaw Active Product Ingredient and finished drug product manufacturing in a quality-controlled environment.• Implemented global internet-based services to allow hospitals to monitor Praxair-offerings, including bulk tank, cylinders, or cryopreservation suites leveraging regional infrastructure and systems.• Instituted healthcare-specific design control procedures for compliance with international regulatory agencies. Renewed focus on risk assessments for safety critical products.

Scoped out new growth initiatives for R&D programs in healthcare applications.• Identified emerging trends, championed ideas within healthcare market for the development of new technology initiatives.• Key member of the global market network, engaging with customers and business/ market internationally. Led quarterly growth initiatives discussions and annual global face to face meetings.• Screened and prioritized ideas considering customer acceptance, impact, business commitment, competing alternatives, intellectual property, technical difficulty, and ability to execute. Defended early stage-gate program reviews to obtain funding of program. Launched an average of 3 new initiatives per year.• Strategically recommended and directed appropriate customer validation activity including direct feedback and focus groups.• Secured business commitment, developed / validated initial business case / value proposition.• Tracked value creation and maintained scorecard for the global market team. Presented to senior management on a quarterly basis.

Managed development of new technology programs.• Developed with outside vendor $50+ MM Praxair Grab'n Go Vantage. Identified in the top 3 R&D projects for the department. More than 500,000 devices in circulation.• Initiated and organized development of Praxair's first portable device with helium/oxygen gas.• Guided Heliox development initiative, including publishing in scientific peer-reviewed journal and presented at international congress. Wrote, designed, and maintained the Praxair Heliox website.